Loading...
Header Logo
Keywords
Last Name
Institution

Andrew Artenstein

Concepts (283)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vaccines
5
2015
48
2.570
Why?
Smallpox Vaccine
5
2013
27
2.000
Why?
Anthrax
8
2012
14
1.570
Why?
Communicable Disease Control
3
2015
22
1.430
Why?
Meningitis, Meningococcal
2
2014
8
1.140
Why?
Smallpox
4
2009
13
1.000
Why?
Bioterrorism
5
2008
17
0.950
Why?
HIV-1
15
2002
571
0.930
Why?
Bacterial Toxins
4
2007
45
0.780
Why?
Military Medicine
2
2009
11
0.780
Why?
Bacillus anthracis
4
2011
12
0.740
Why?
Patient Care Team
2
2017
188
0.730
Why?
Military Personnel
4
2009
40
0.730
Why?
Mass Vaccination
2
2014
2
0.730
Why?
Vaccination
2
2015
129
0.710
Why?
Needles
2
2013
40
0.710
Why?
Academic Medical Centers
1
2017
172
0.710
Why?
Humans
53
2017
34160
0.700
Why?
Virology
2
2013
11
0.680
Why?
Meningococcal Vaccines
2
2014
23
0.680
Why?
Length of Stay
1
2017
400
0.660
Why?
Delivery of Health Care
1
2017
162
0.660
Why?
HIV Infections
10
2002
655
0.660
Why?
Teaching Rounds
1
2015
5
0.650
Why?
Antigens, Bacterial
3
2007
161
0.650
Why?
Poliomyelitis
1
2014
3
0.610
Why?
Emergency Service, Hospital
1
2017
363
0.570
Why?
Disease Outbreaks
2
2012
58
0.560
Why?
Tobacco Mosaic Virus
1
2012
9
0.540
Why?
Plant Diseases
1
2012
8
0.540
Why?
Proprotein Convertases
1
2011
3
0.530
Why?
Physician's Role
2
2003
98
0.520
Why?
Sepsis
1
2013
139
0.520
Why?
Tobacco
1
2012
62
0.510
Why?
Vaccinia virus
2
2008
101
0.480
Why?
History, 20th Century
4
2012
172
0.450
Why?
Communicable Diseases
2
2011
55
0.440
Why?
Nucleic Acid Amplification Techniques
3
2013
17
0.410
Why?
Virulence Factors
2
2007
55
0.400
Why?
RNA, Viral
4
2013
196
0.390
Why?
Vaccinia
1
2005
42
0.320
Why?
Chloroquine
1
2004
38
0.310
Why?
Influenza, Human
4
2013
112
0.310
Why?
Botulinum Toxins
1
2003
7
0.290
Why?
Acquired Immunodeficiency Syndrome
4
1997
125
0.290
Why?
Africa South of the Sahara
2
2014
13
0.290
Why?
Skin Diseases, Bacterial
1
2003
7
0.290
Why?
Hospitalization
2
2017
637
0.260
Why?
Skin
1
2003
229
0.250
Why?
Immunity, Mucosal
3
1999
44
0.250
Why?
Polymerase Chain Reaction
5
2012
452
0.250
Why?
HIV Antibodies
4
1999
117
0.240
Why?
Anti-Infective Agents
2
2012
68
0.240
Why?
HIV Envelope Protein gp120
5
2002
116
0.240
Why?
DNA Probes
2
2012
38
0.230
Why?
Influenza A Virus, H5N1 Subtype
2
2011
12
0.220
Why?
Endotoxins
2
2010
59
0.220
Why?
History, 19th Century
2
2012
48
0.210
Why?
History, 21st Century
2
2012
83
0.210
Why?
Alpha-Globulins
2
2011
3
0.210
Why?
Patient Dropouts
1
2017
39
0.190
Why?
Efficiency, Organizational
1
2017
56
0.190
Why?
Patient Admission
1
2017
101
0.180
Why?
Virus Diseases
2
2012
107
0.180
Why?
Influenza A Virus, H3N2 Subtype
2
2013
26
0.180
Why?
Genes, nef
1
1996
6
0.180
Why?
Adult
16
2013
9698
0.180
Why?
Patient Discharge
1
2017
214
0.170
Why?
Influenza A Virus, H1N1 Subtype
2
2013
71
0.170
Why?
Tuberculosis, Lymph Node
1
1995
2
0.170
Why?
Pilot Projects
2
2015
497
0.160
Why?
Mycobacterium haemophilum
1
1994
1
0.160
Why?
Mycobacterium Infections
1
1994
11
0.160
Why?
Poliovirus Vaccines
1
2014
2
0.150
Why?
Poliovirus
1
2014
8
0.150
Why?
Cost-Benefit Analysis
1
2015
179
0.150
Why?
Health Education
1
2015
173
0.150
Why?
Bacterial Vaccines
2
2010
43
0.150
Why?
United States
6
2005
4021
0.150
Why?
Immunomodulation
1
2013
13
0.150
Why?
Lipopolysaccharides
3
2010
516
0.150
Why?
International Cooperation
1
2014
57
0.150
Why?
Drug Industry
1
2014
30
0.150
Why?
Anti-Bacterial Agents
3
2003
382
0.150
Why?
Molecular Diagnostic Techniques
1
2013
12
0.150
Why?
Dacryocystitis
1
1993
4
0.140
Why?
Tracheal Diseases
1
2013
5
0.140
Why?
Eye Infections, Bacterial
1
1993
3
0.140
Why?
Molecular Sequence Data
9
2011
2049
0.140
Why?
Peptide Fragments
1
1995
292
0.140
Why?
Bacteriology
1
2012
1
0.140
Why?
Female
15
2010
18881
0.140
Why?
Antitoxins
1
2012
2
0.130
Why?
Phylogeny
4
1998
239
0.130
Why?
Thailand
6
1999
90
0.130
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
530
0.130
Why?
Viruses
1
2012
62
0.130
Why?
Hyperlipidemias
1
2011
50
0.130
Why?
Herpesvirus 1, Cercopithecine
1
1991
1
0.120
Why?
Research
1
2012
138
0.120
Why?
Time Factors
1
2017
2605
0.120
Why?
Veterinary Medicine
1
1991
12
0.120
Why?
Herpesviridae Infections
1
1991
31
0.120
Why?
Disaster Planning
2
2008
30
0.120
Why?
Base Sequence
5
2011
1245
0.120
Why?
Immunotherapy
1
2012
102
0.120
Why?
Health Knowledge, Attitudes, Practice
1
2015
560
0.120
Why?
Spleen
3
2011
454
0.120
Why?
Cells, Cultured
2
2005
1799
0.120
Why?
Male
13
2011
17242
0.120
Why?
Tularemia
1
2010
11
0.110
Why?
Francisella tularensis
1
2010
18
0.110
Why?
RNA
1
2012
284
0.110
Why?
Animals
9
2011
14706
0.110
Why?
Alzheimer Disease
1
2011
216
0.110
Why?
Inflammation
1
2013
666
0.110
Why?
Biological Warfare Agents
1
2008
3
0.110
Why?
Cyclonic Storms
1
2008
3
0.110
Why?
Occupational Diseases
1
1991
228
0.100
Why?
Rescue Work
1
2008
11
0.100
Why?
Vaccines, Attenuated
1
2008
30
0.100
Why?
Frail Elderly
1
2008
43
0.100
Why?
Disaster Medicine
1
2008
4
0.100
Why?
Survival Analysis
2
2010
381
0.100
Why?
Diagnosis, Differential
3
2013
637
0.100
Why?
Macrophages, Peritoneal
2
2005
69
0.100
Why?
Child
1
2014
2648
0.090
Why?
Mice, Inbred BALB C
2
2010
806
0.090
Why?
Young Adult
1
2014
2167
0.090
Why?
Internal Medicine
1
2008
128
0.090
Why?
Immunoglobulin A
3
2010
41
0.090
Why?
Education, Medical, Graduate
1
2008
111
0.090
Why?
Transcription, Genetic
1
2011
786
0.090
Why?
Neoplasms
1
2011
599
0.090
Why?
Furin
1
2005
2
0.080
Why?
Pericarditis
1
2005
6
0.080
Why?
Nursing Homes
1
2008
282
0.080
Why?
History, 18th Century
1
2005
10
0.080
Why?
Immunoglobulin G
3
2010
337
0.080
Why?
Neutralization Tests
1
2005
122
0.080
Why?
Specific Pathogen-Free Organisms
1
2004
44
0.080
Why?
Leukocyte Count
1
2004
81
0.080
Why?
Amino Acid Sequence
6
1998
1491
0.080
Why?
Double-Blind Method
1
2005
489
0.070
Why?
Antibodies, Viral
1
2005
224
0.070
Why?
Cell Death
1
2004
208
0.070
Why?
Biomedical Research
1
2005
142
0.070
Why?
Soft Tissue Infections
1
2003
24
0.070
Why?
Mice
4
2011
7381
0.070
Why?
Rats
1
2007
1762
0.070
Why?
Cell Survival
1
2004
450
0.070
Why?
Chronic Disease
3
2013
536
0.070
Why?
Dose-Response Relationship, Drug
1
2004
694
0.070
Why?
Neutrophils
1
2004
265
0.070
Why?
Monocytes
1
2004
299
0.070
Why?
Botulism
1
2002
1
0.070
Why?
Education, Medical, Continuing
1
2002
94
0.060
Why?
Bacterial Infections
1
2002
85
0.060
Why?
Enzyme-Linked Immunosorbent Assay
3
1997
402
0.060
Why?
HIV Envelope Protein gp160
2
1999
6
0.060
Why?
DNA, Viral
3
1996
192
0.060
Why?
Cervix Uteri
2
1999
43
0.060
Why?
Middle Aged
5
2002
9874
0.060
Why?
Asia
2
1996
11
0.060
Why?
Internet
1
2003
358
0.060
Why?
Disease Models, Animal
1
2004
1190
0.050
Why?
Receptors, CCR5
1
1999
35
0.050
Why?
Travel
2
1995
20
0.050
Why?
Adolescent
2
2005
4025
0.050
Why?
Sexual Behavior
2
1999
141
0.050
Why?
Treatment Outcome
1
2005
2667
0.050
Why?
Aged
3
2008
7641
0.050
Why?
Nasal Mucosa
1
1997
13
0.050
Why?
Parotid Gland
1
1997
7
0.050
Why?
Genitalia, Female
1
1997
17
0.050
Why?
Immunoglobulin M
1
1997
102
0.050
Why?
Liver
2
2011
542
0.050
Why?
Immunoglobulins
1
1997
74
0.050
Why?
Genes, gag
1
1996
11
0.050
Why?
Genes, env
1
1996
13
0.050
Why?
Mosaicism
1
1996
20
0.050
Why?
Uruguay
1
1995
1
0.040
Why?
Cambodia
1
1995
6
0.040
Why?
Viral Envelope Proteins
1
1996
82
0.040
Why?
Sequence Homology, Amino Acid
1
1996
342
0.040
Why?
Rifampin
1
1994
20
0.040
Why?
Ciprofloxacin
1
1994
13
0.040
Why?
DNA, Ribosomal
1
1994
30
0.040
Why?
Lymphoma, Non-Hodgkin
1
1994
32
0.040
Why?
ADP Ribose Transferases
1
1994
61
0.040
Why?
Escherichia coli Infections
1
1994
41
0.040
Why?
Abscess
1
1994
61
0.040
Why?
Cloning, Molecular
1
1995
360
0.040
Why?
Fatty Acids
1
1994
134
0.040
Why?
Leukocytes, Mononuclear
1
1995
214
0.040
Why?
Sequence Analysis, DNA
1
1995
308
0.040
Why?
Drug Therapy, Combination
1
1994
344
0.040
Why?
Oligonucleotide Probes
1
2013
42
0.040
Why?
Antibodies, Bacterial
2
2010
129
0.040
Why?
Dacryocystorhinostomy
1
1993
3
0.040
Why?
Nasolacrimal Duct
1
1993
4
0.040
Why?
DNA, Bacterial
1
1994
217
0.040
Why?
Airway Obstruction
1
2013
18
0.040
Why?
Spirometry
1
2013
40
0.040
Why?
Genetic Variation
1
1995
255
0.040
Why?
DNA, Single-Stranded
1
2013
49
0.040
Why?
Pulmonary Ventilation
1
2013
31
0.040
Why?
Bronchoscopy
1
2013
38
0.040
Why?
Seasons
1
2013
95
0.040
Why?
Prevalence
1
1995
795
0.040
Why?
Anaplasmataceae
1
1992
1
0.030
Why?
Rickettsiaceae Infections
1
1992
5
0.030
Why?
Arachnid Vectors
1
1992
9
0.030
Why?
Ticks
1
1992
15
0.030
Why?
DNA Ligases
1
2012
4
0.030
Why?
Ligase Chain Reaction
1
2012
2
0.030
Why?
Aza Compounds
1
2011
1
0.030
Why?
Fluoroquinolones
1
2011
6
0.030
Why?
Quinolines
1
2011
23
0.030
Why?
Diagnostic Imaging
1
2013
167
0.030
Why?
Algorithms
1
1995
633
0.030
Why?
Escherichia coli
1
1994
557
0.030
Why?
Macaca mulatta
1
1991
162
0.030
Why?
Serum
1
2010
26
0.030
Why?
Colony Count, Microbial
1
2010
48
0.030
Why?
Bronchoalveolar Lavage Fluid
1
2010
64
0.030
Why?
Limulus Test
1
1989
1
0.030
Why?
Nephelometry and Turbidimetry
1
1989
11
0.030
Why?
Temperature
1
2011
249
0.030
Why?
Polymorphism, Single Nucleotide
1
2012
323
0.030
Why?
Nucleic Acid Conformation
1
2011
181
0.030
Why?
Aminoglycosides
1
1989
14
0.030
Why?
Neisseria meningitidis
1
2010
79
0.030
Why?
HIV Seronegativity
2
1999
18
0.030
Why?
Louisiana
1
2008
13
0.030
Why?
Florida
1
2008
23
0.030
Why?
Hybridization, Genetic
1
2008
13
0.030
Why?
Molecular Epidemiology
2
1998
15
0.030
Why?
Competency-Based Education
1
2008
16
0.020
Why?
Problem-Based Learning
1
2008
23
0.020
Why?
Patient Simulation
1
2008
38
0.020
Why?
Thermodynamics
1
2008
185
0.020
Why?
Lung
1
2010
470
0.020
Why?
Genotype
2
1999
480
0.020
Why?
Bacterial Proteins
1
2010
564
0.020
Why?
Internship and Residency
1
2008
353
0.020
Why?
Antibody Specificity
1
2002
95
0.020
Why?
Statistics as Topic
1
2002
136
0.020
Why?
Risk Factors
2
1999
3030
0.020
Why?
Aged, 80 and over
1
2008
2864
0.020
Why?
Needle Sharing
1
1999
6
0.010
Why?
Malaysia
1
1998
2
0.010
Why?
Immunoglobulin A, Secretory
1
1999
3
0.010
Why?
Seroepidemiologic Studies
1
1999
17
0.010
Why?
Body Fluids
1
1999
15
0.010
Why?
Genes, MHC Class I
1
1999
23
0.010
Why?
Vagina
1
1999
58
0.010
Why?
Korea
1
1997
3
0.010
Why?
CD4 Lymphocyte Count
1
1997
85
0.010
Why?
Longitudinal Studies
1
1999
693
0.010
Why?
Nucleic Acid Heteroduplexes
1
1996
13
0.010
Why?
Serotyping
1
1996
57
0.010
Why?
Genes, pol
1
1996
2
0.010
Why?
HIV Long Terminal Repeat
1
1996
16
0.010
Why?
Case-Control Studies
1
1999
660
0.010
Why?
Consensus Sequence
1
1996
32
0.010
Why?
Africa
1
1996
18
0.010
Why?
Sequence Homology, Nucleic Acid
1
1996
112
0.010
Why?
Enhancer Elements, Genetic
1
1996
64
0.010
Why?
HIV Envelope Protein gp41
1
1996
19
0.010
Why?
HIV Seropositivity
1
1996
73
0.010
Why?
Antigens, CD4
1
1996
123
0.010
Why?
O Antigens
1
1994
4
0.010
Why?
Exotoxins
1
1994
5
0.010
Why?
Cohort Studies
1
1999
1417
0.010
Why?
Polysaccharides, Bacterial
1
1994
43
0.010
Why?
Antibody Formation
1
1994
103
0.010
Why?
NF-kappa B
1
1996
386
0.010
Why?
Binding Sites
1
1996
749
0.010
Why?
Peptides
1
1996
418
0.010
Why?
Promoter Regions, Genetic
1
1996
579
0.010
Why?
Recombinant Fusion Proteins
1
1994
477
0.010
Why?
Prospective Studies
1
1997
1668
0.010
Why?
Artenstein's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_